Emerald Innovations

Emerald Innovations, a spin-off from MIT, is transforming digital health monitoring from wearable devices to invisible devices. It is based on an AI-driven sensor that continuously measures motion, vital signs, sleep, and behavior by analyzing wireless signals bouncing off the environment. Emerald's passive technology eliminates the need for patients to wear devices on their bodies. Emerald is used in all phases of clinical trials by the world’s largest pharmaceutical and biotechnology companies as well as leading disease research foundations across various therapeutic areas (neurology, immunology, and rare diseases).